Zoekresultaten - 32 results
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Cervical Neoplasms Abstract: In 2012, VAL idation of human papillomavirus (HPV) GEN otyping T ests (VALGENT) was initiated to provide a formalized and uniform study framework for comparison and validation of ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
(hrHPV) types is more effective than cytology-based screening. This study completes the diagnostic accuracy assessment conducted previously within the framework of VALGENT-2 (Validation of HPV genotyping ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
cervical precancer. However, insufficient evidence is available for specific HPV assay/self-sample device combinations. OBJECTIVES: The VALHUDES protocol is designed as a diagnostic test accuracy study that ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...
VALGENT: A protocol for clinical validation of human papillomavirus assays.
Vaginal Smears Validation Studies as Topic Abstract: BACKGROUND: Testing for high-risk HPV is more effective in primary cervical cancer screening than the cytological examination of a Pap smear. Separate ...
Early effects of human papillomavirus vaccination in Belgium.
Infections Papillomavirus Vaccines Poisson Distribution prevalence regression analysis Retrospective Studies Uterine Cervical Neoplasms Vaginal Smears Young adult Abstract: Human papillomavirus (HPV ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Oligonucleotide Probes Papillomaviridae Papillomavirus Infections Reference Standards Sensitivity and Specificity Young adult Abstract: The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5 ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Trottier, Helen Source: The Lancet Oncology, Volume 15, Issue 12 (2014) Keywords: HPV DNA meta-analyses neck cancer Abstract: BACKGROUND We aimed to provide updated information about the global estimates of ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Keywords: clinical efficacy immunogenicity prophylactic HPV vaccines Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
of human papillomavirus (HPV) vaccine introduction in Belgium. Information on vaccine use is based on sales statistics and reimbursement claims. From November 2007 to November 2008, the National ...